No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antihypertensive Agents / therapeutic use
-
Apolipoprotein B-100 / antagonists & inhibitors
-
Blood Platelets / physiology
-
CCR5 Receptor Antagonists
-
Chemokine CCL5 / antagonists & inhibitors
-
Cholesterol, HDL / drug effects
-
Coronary Artery Disease / pathology
-
Coronary Artery Disease / prevention & control
-
Cytokines / metabolism
-
Diagnostic Imaging
-
Endothelium, Vascular / physiology
-
Genetic Testing
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypolipidemic Agents / therapeutic use
-
Intercellular Signaling Peptides and Proteins / metabolism
-
Leukocytes / pathology
-
Neovascularization, Physiologic / physiology
-
Niacin / therapeutic use
-
Peptide Hydrolases / physiology
-
Phospholipases / antagonists & inhibitors
-
Plaque, Atherosclerotic / etiology
-
Plaque, Atherosclerotic / pathology
-
Plaque, Atherosclerotic / prevention & control*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Proprotein Convertase 9
-
Proprotein Convertases / antagonists & inhibitors
-
Receptors, CCR5
-
Serine Endopeptidases
-
Smoking / adverse effects
-
Stem Cells / physiology
-
Stress, Physiological / physiology
Substances
-
Antihypertensive Agents
-
Apolipoprotein B-100
-
CCL5 protein, human
-
CCR5 Receptor Antagonists
-
CCR5 protein, human
-
Chemokine CCL5
-
Cholesterol, HDL
-
Cytokines
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Hypolipidemic Agents
-
Intercellular Signaling Peptides and Proteins
-
Platelet Aggregation Inhibitors
-
Receptors, CCR5
-
Niacin
-
Phospholipases
-
Peptide Hydrolases
-
PCSK9 protein, human
-
Proprotein Convertase 9
-
Proprotein Convertases
-
Serine Endopeptidases